7-KetoisodrimeninCAS# 73036-54-1 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 73036-54-1 | SDF | Download SDF |
| PubChem ID | 13281820 | Appearance | Cryst. |
| Formula | C15H20O3 | M.Wt | 248.32 |
| Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (5aS,9aS)-6,6,9a-trimethyl-3,5,5a,7,8,9-hexahydrobenzo[g][2]benzofuran-1,4-dione | ||
| SMILES | CC1(CCCC2(C1CC(=O)C3=C2C(=O)OC3)C)C | ||
| Standard InChIKey | DUXBZCLJTPCFOX-NHYWBVRUSA-N | ||
| Standard InChI | InChI=1S/C15H20O3/c1-14(2)5-4-6-15(3)11(14)7-10(16)9-8-18-13(17)12(9)15/h11H,4-8H2,1-3H3/t11-,15-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
7-Ketoisodrimenin Dilution Calculator
7-Ketoisodrimenin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.0271 mL | 20.1353 mL | 40.2706 mL | 80.5412 mL | 100.6765 mL |
| 5 mM | 0.8054 mL | 4.0271 mL | 8.0541 mL | 16.1082 mL | 20.1353 mL |
| 10 mM | 0.4027 mL | 2.0135 mL | 4.0271 mL | 8.0541 mL | 10.0677 mL |
| 50 mM | 0.0805 mL | 0.4027 mL | 0.8054 mL | 1.6108 mL | 2.0135 mL |
| 100 mM | 0.0403 mL | 0.2014 mL | 0.4027 mL | 0.8054 mL | 1.0068 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Glabratine
Catalog No.:BCN9682
CAS No.:142750-47-8
- Integracin B
Catalog No.:BCN9681
CAS No.:224186-05-4
- Muricarpone B
Catalog No.:BCN9680
CAS No.:886226-15-9
- Spirotryprostatin A
Catalog No.:BCN9679
CAS No.:182234-25-9
- Jaslanceoside B
Catalog No.:BCN9678
CAS No.:188300-82-5
- 10-Epiteuclatriol
Catalog No.:BCN9677
CAS No.:151563-36-9
- 8-Methoxyfissistigine C
Catalog No.:BCN9676
CAS No.:20824-18-4
- Dehydroacerogenin C
Catalog No.:BCN9675
CAS No.:152041-27-5
- Cerebroside D
Catalog No.:BCN9674
CAS No.:113773-89-0
- 3-Hydroxychimaphilin
Catalog No.:BCN9673
CAS No.:33253-99-5
- 5-O-Ethylcleroindicin D
Catalog No.:BCN9672
CAS No.:488138-32-5
- (2Z,6Z,10E,14E,18E)-Farnesylfarnesol
Catalog No.:BCN9671
CAS No.:90695-03-7
- Kmeriol
Catalog No.:BCN9684
CAS No.:54306-10-4
- Periplocogenin
Catalog No.:BCN9685
CAS No.:112899-63-5
- 3β-Hydroxycinnamolide
Catalog No.:BCN9686
CAS No.:124987-03-7
- Jasamplexoside C
Catalog No.:BCN9687
CAS No.:147742-02-7
- Triandrin
Catalog No.:BCN9688
CAS No.:19764-35-3
- Jasamplexoside A
Catalog No.:BCN9689
CAS No.:147764-93-0
- 1,1'-bislusianthridin
Catalog No.:BCN9690
CAS No.:182296-65-7
- Methyl lucidenate L
Catalog No.:BCN9691
CAS No.:110267-46-4
- Murrayamine O
Catalog No.:BCN9692
CAS No.:166990-10-9
- Icariside E4
Catalog No.:BCN9693
CAS No.:126253-42-7
- Hancinone
Catalog No.:BCN9694
CAS No.:104013-61-8
- 1,5-Dihydroxy-6,7-dimethoxyxanthone
Catalog No.:BCN9695
CAS No.:38710-31-5
Xylodon flaviporus-Derived Drimane Sesquiterpenoids That Inhibit Osteoclast Differentiation.[Pubmed:31599157]
J Nat Prod. 2019 Oct 25;82(10):2835-2841.
The presence of excessive osteoclasts is a major factor in skeletal diseases. The present study aimed to discover osteoclast differentiation inhibitors from the basidiomycete Xylodon flaviporus. Seven new drimane sesquiterpenoids (1-7) and 7-Ketoisodrimenin-5-ene (8) were obtained and characterized by various spectroscopic methods. The isolated compounds were evaluated for their inhibitory effects against receptor activator of nuclear factor-kappa-B ligand-induced osteoclastogenesis in mouse bone marrow macrophages. Compounds 1, 3, and 6 showed potent activities with IC50 values of 1.6, 0.9, and 2.1 muM, respectively, while 4, 5, and 7 exhibited relatively weak activities with IC50 values of 10.7, 10.1, and 8.5 muM, respectively.
Drimane-type sesquiterpenes from Polygonum hydropiper.[Pubmed:21674440]
Planta Med. 2011 Nov;77(16):1848-51.
One new drimane-type sesquiterpenoid, 3 beta-angeloyloxy-7-epifutronolide (1), and one new natural product, polygonumate (2), along with six known drimane-type sesquiterpenes [dendocarbin L (3), (+) winterin (4), (+) fuegin (5), changweikangic acid A (6), futronolide (7), and 7-Ketoisodrimenin (8)] were isolated from the whole plant of Polygonum hydropiper Linn. Their structures were determined using spectroscopic techniques. Single-crystal X-ray diffraction study on dendocarbin L (3) and (1)(3)C-NMR spectroscopic data of (+) winterin (4) are described for the first time. Compound 6 was evaluated for inhibitions of alpha-chymotrypsin, acetylcholinesterase, and butyrylcholinesterase enzymes.
Cytotoxic sesquiterpenoids from Winteraceae of Caledonian rainforest.[Pubmed:19251287]
Phytochemistry. 2009 Mar;70(4):546-53.
One secobutanolide, two butanolides and six drimane sesquiterpenoids were isolated from the bark and leaves of Zygogynum pancheri and Zygogynum acsmithii (Winteraceae) along with six known drimanes, isodrimanial, 1beta-O-p-methoxy-E-cinnamoyl-bemadienolide, 7-Ketoisodrimenin, drimenin, polygodial and 1beta-E-cinnamoyl-6alpha-hydroxypolygodial. Their structures were elucidated through analysis of spectroscopic data. Drimane sesquiterpenoids with a dialdehyde function exhibited significant inhibitory activities in the in vitro cytotoxic assays against KB, HL60 and HCT116 cancer cell lines.
Bioactive and other sesquiterpenoids from Porella cordeana.[Pubmed:8350093]
J Nat Prod. 1993 Jun;56(6):921-5.
Bioassay-directed fractionation of the MeCOEt extract of Porella cordeana yielded drimenin [1] and aristolone [4], which were moderately toxic towards DNA-repair-deficient mutants of Saccharomyces cerevisiae. Three inactive sesquiterpenes, 7-Ketoisodrimenin [2], 7-Ketoisodrimenin-5-ene [3], and norpinguisanolide, were also obtained. Compounds 2 and 3 are new.
